These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway. Li M, Zhou H, Di J, Yang M, Jia F. Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):289-296. PubMed ID: 30657569 [Abstract] [Full Text] [Related]
3. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling. Cai T, Sun D, Duan Y, Qiu Y, Dai C, Yang J, He W. J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729 [Abstract] [Full Text] [Related]
4. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling. Duan Y, Qiu Y, Huang X, Dai C, Yang J, He W. J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599 [Abstract] [Full Text] [Related]
17. HGF alleviates renal interstitial fibrosis via inhibiting the TGF-β1/SMAD pathway. Xu J, Yu TT, Zhang K, Li M, Shi HJ, Meng XJ, Zhu LS, Zhu LK. Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7621-7627. PubMed ID: 30536302 [Abstract] [Full Text] [Related]
18. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction. Liu B, Ding FX, Liu Y, Xiong G, Lin T, He DW, Zhang YY, Zhang DY, Wei GH. Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820 [Abstract] [Full Text] [Related]